Reducing unnecessary urgent care visits
A convenient set of information and assets to help you spread the good word.
Infermedica tackles the problem of inappropriate use of medical services and misdiagnosis, providing insurance companies, hospitals, and health systems with a set of advanced preliminary diagnosis and triage tools. They provide four different products: Symptom Checker, Call Center Triage, Covid-19 Risk Assessment Tool, and Infermedica API.
Founded in 2012 by a team of engineers, data scientists, and physicians, Infermedica develops its diagnostic engine to collect intake data, check symptoms, and guide patients to the right care. The technology can also detect emergencies and support healthcare professionals by giving them early access to health information and recommendations.
“The broader goal is to improve customers’ performance, increase healthcare accessibility, and reduce costs. To date, our tools have been used by over 7 million users worldwide, and we are working with more than 70 companies, including Allianz Worldwide Partners, Microsoft, Global Excel, Médis, PZU Zdrowie, Sana Kliniken, or Everyday Health,” says Piotr Orzechowski, Infermedica’s CEO.
The company uses artificial intelligence and machine learning to assess symptoms and find patterns in data. Thanks to algorithms, Infermedica gets smarter over time. Additionally, the team of physicians verifies every piece of information that is added to the medical database to ensure that patients get safe and reliable recommendations. To date, physicians involved in the project have spent over 40,000 hours on reviews.
Infermedica’s core product is the symptom checker, which allows patients to take part in a preliminary diagnostic interview. The AI suggests the most suitable action to take in a given case. Depending on the severity of the symptoms, the recommendation might be to see or call a doctor, self-care treatment, or a visit to an emergency department. Infermedica assists patients in making the best decisions regarding their symptoms, and at the same time allows healthcare companies to save money by making sure patients use the right services to treat their health issues.
Over the last year, Infermedica grew into a team of 120 people, and its products were translated into 18 languages, making them available in countries such as China and the United Arab Emirates.
August 18, 2020
August 11, 2020
May 21, 2019
Feel free to contact our communications team for more information, media inquiries, event organization, and interviews.